Researchers have found that Sotyktu, which inhibits the protein TYK2, protects insulin-producing beta cells and, at the same ...

KEY HIGHLIGHTS First patient expected to start therapy by end of Q2-2025 in Phase 2a proof-of concept clinical trial for ...

Disney’s newly elevated merch isn’t limited to fashion. Swarovski offers a crystal-studded Bambi figurine that retails for ...

Discovery of innate immune receptor "brake" Siglec-E offers a novel therapeutic target to prevent organ transplant rejection ...

A protein identified by researchers at UT Southwestern Medical Center may drive resistance to immune checkpoint inhibitors, a ...

Each human kidney has about 1 to 2 million filtering units called nephrons that help purify our blood and remove waste ...

Cancer before age 50 is rare, but increasing, in the United States and researchers want to know why. A new government study ...

Researchers identified a natural 'brake' within the innate immune system: the inhibitory receptor Siglec-E (SigE) and its human counterparts, Siglec-7 and Siglec-9. This receptor helps prevent ...

Current treatments to prevent organ transplant rejection focus mainly on suppressing T cells, part of the adaptive immune ...

Volume 17, Issue 4, on April 2, 2025, titled "Fisetin ameliorates vascular smooth muscle cell calcification via DUSP1-dependent p38 MAPK inhibition." ...

Fisetin treatment suppressed calcific marker expression and calcification of VSMCs as well as p38 MAPK phosphorylation induced by pro-calcific ...

In some cases damage to the kidneys can lead to kidney disease. According to the NHS, chronic kidney disease is a common condition often associated with getting older but lifestyle changes can ...